NEJM vs The Lancet

2026 data, updated August 2026

NEJM is the more cited journal: its 2026 Journal Metrics Score is 29.8 against 19.7 for The Lancet, about 51% higher. Both are Q1 journals in their best subfield. The Lancet is the larger journal, with 1,484 papers in 2025 against 987 for NEJM.

Side-by-side numbers

MeasureNEJMThe Lancet
2026 Journal Metrics Score29.819.7
Best subfield quartileQ1Q1
Rank in field#10 of 6,272 in Medicine#23 of 6,272 in Medicine
Acceptance rate (publisher-reported)Not publishedNot published
Median days, submission to acceptanceNo PubMed data41 days
Access modelSubscription or hybridSubscription or hybrid
Indicative APC (OpenAlex)None on record$6,830
Papers published in 20259871,484
h-index (OpenAlex)1,5071,207
PublisherMassachusetts Medical SocietyElsevier BV

Bold marks the stronger figure where one direction is better. Journal Metrics Score is a two-year citation average; quartiles and field ranks are computed within OpenAlex subfields and site fields. Data source: OpenAlex (CC0). Submission-to-acceptance days come from PubMed received and accepted dates and include revisions. Acceptance rates appear only where the publisher publishes one. APCs are indicative OpenAlex values.

Which should you choose?

Choose NEJM if

  • you want the venue whose recent papers are cited more

Fit with each journal's scope matters more than any single number. Read a few recent papers in your topic in both journals before deciding.

Common questions about NEJM vs The Lancet

Is NEJM better than The Lancet?

NEJM is the more cited journal: its 2026 Journal Metrics Score is 29.8 against 19.7 for The Lancet, about 51% higher. Both are Q1 journals in their best subfield. Which is better for your paper depends on its scope and how broad the result is; citation data measures the journals, not individual papers.

Is it easier to get into NEJM or The Lancet?

NEJM does not publish an acceptance rate. The Lancet does not publish an acceptance rate. Without published rates for both, compare their field rank and scope instead.

Are NEJM and The Lancet open access?

NEJM is not fully open access. The Lancet is not fully open access; OpenAlex lists an indicative open-access fee of $6,830. Confirm current fees on each journal's website.